1. Breast Cancer Screening and Diagnosis, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology.
2. Breast Cancer Risk Reduction, Version 1.2021, NCCN Clinical Practice Guidelines in Oncology.
3. Pal Choudhury, P., Brook, M.N., Hurson, A.N. et al. Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry. Breast Cancer Res 23, 22 (2021). https://doi.org/10.1186/s13058-021-01399-7
4. Carver, T. et al. CanRisk Tool—A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants. Cancer Epidemiol Biomarkers Prev (2020).
5. Terry, M.B., Liao, Y., Whittemore, A.S., Leoce, N., Buchsbaum, R., Zeinomar, N., Dite, G.S., Chung, W.K., Knight, J.A., Southey, M.C. and Milne, R.L., 2019. 10-year performance of four models of breast cancer risk: a validation study. The Lancet Oncology, 20(4), pp.504-517.
6. Breast Cancer Genetics Referral Screening Tool (B-RSTTM 3.1)



mapБул.Свети Наум 51, 1164, София, България


mapТел: 0883427500